At present, other prognostic markers for immunotherapy of HNSCC have been found, including tertiary lymphoid structures (TLSs) (46), Interferon-γ (IFN-γ) (47), TILs (48, 49), CTLA-4 (50). The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.